{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:53:14Z","timestamp":1789735994540,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31600773"],"award-info":[{"award-number":["31600773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T12:11:20Z","timestamp":1662984680000},"page":"789-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity"],"prefix":"10.1016","volume":"350","author":[{"given":"Keke","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.006_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000519635","article-title":"Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies","volume":"119","author":"Yu","year":"2022","journal-title":"Neonatology"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0015","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1167\/iovs.05-1473","article-title":"The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy","volume":"47","author":"Neu","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0020","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/jcb.26473","article-title":"Effects of apelin on retinal microglial cells in a rat model of oxygen-induced retinopathy of prematurity","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/08164622.2021.1878818","article-title":"Outcome of 532 nm Nd:YAG laser photocoagulation in retinopathy of prematurity from a referral center","volume":"104","author":"Sizmaz","year":"2021","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.eye.6700030","article-title":"Retinopathy of prematurity in the UK I: the organisation of services for screening and treatment","volume":"16","author":"Haines","year":"2002","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0040","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1167\/iovs.13-13397","article-title":"Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy","volume":"55","author":"Tokunaga","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0045","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nprot.2017.032","article-title":"Comprehensive analysis of mouse retinal mononuclear phagocytes","volume":"12","author":"L\u00fcckoff","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0050","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/10717544.2018.1474967","article-title":"Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization","volume":"25","author":"Mu","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0055","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2147\/OPTH.S171636","article-title":"Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment","volume":"12","author":"Pongsachareonnont","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0060","first-page":"574","article-title":"Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization","volume":"18","author":"Miao","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/IAE.0000000000000311","article-title":"Associations of inflammatory cytokines with choroidal neovascularization in highly myopic eyes","volume":"35","author":"Yamamoto","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8546423","article-title":"Levels of inflammatory cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in aqueous humour of patients with diabetic retinopathy","volume":"2018","author":"Feng","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12886-017-0572-6","article-title":"Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","article-title":"Retinal microglia: just bystander or target for therapy?","volume":"45","author":"Karlstetter","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2013.03.033","article-title":"Development of the microglial phenotype in culture","volume":"241","author":"Szabo","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00011-020-01427-w","article-title":"The phase changes of M1\/M2 phenotype of microglia\/macrophage following oxygen-induced retinopathy in mice","volume":"70","author":"Li","year":"2021","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0105","article-title":"Engineering bacteria-activated multifunctionalized hydrogel for promoting diabetic wound healing","volume":"21","author":"Lu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd8217","article-title":"Sulfated polysaccharide directs therapeutic angiogenesis via endogenous VEGF secretion of macrophages","volume":"7","author":"Yu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12660","article-title":"Melatonin attenuates choroidal neovascularization by regulating macrophage\/microglia polarization via inhibition of RhoA\/ROCK signaling pathway","volume":"69","author":"Xu","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119567","article-title":"Asiatic acid attenuates diabetic retinopathy through TLR4\/MyD88\/NF-\u03baB p65 mediated modulation of microglia polarization","volume":"277","author":"Fang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/mt.2008.104","article-title":"MicroRNAs regulate ocular neovascularization","volume":"16","author":"Shen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0145","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s00018-012-0976-7","article-title":"The physiological impact of microRNA gene regulation in the retina","volume":"69","author":"Sundermeier","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218282","article-title":"MicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model","volume":"14","author":"Desjarlais","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0155","article-title":"The impact of miRNAs in health and disease of retinal pigment epithelium","volume":"8","author":"Intartaglia","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/aos.13407","article-title":"Dissecting microRNA dysregulation in age-related macular degeneration: new targets for eye gene therapy","volume":"96","author":"Askou","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2020.00276","article-title":"MicroRNA-18a-5p administration suppresses retinal neovascularization by targeting FGF1 and HIF1A","volume":"11","author":"Guan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0170","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1073\/pnas.1508426112","article-title":"Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization","volume":"112","author":"Liu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0175","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.113.301824","article-title":"MicroRNA-223 antagonizes angiogenesis by targeting \u03b21 integrin and preventing growth factor signaling in endothelial cells","volume":"113","author":"Shi","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jcp.26871","article-title":"MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy","volume":"234","author":"Xia","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/mt.2016.108","article-title":"Strand and cell type-specific function of microRNA-126 in angiogenesis","volume":"24","author":"Zhou","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0190","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fcell.2020.00516","article-title":"MicroRNA-223 regulates retinal function and inflammation in the healthy and degenerating retina","volume":"8","author":"Fernando","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/glia.23576","article-title":"MiR-223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system","volume":"67","author":"Galloway","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1242551","article-title":"Medicine. Gene therapy that works","volume":"341","author":"Verma","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10856-018-6069-x","article-title":"Mesoporous silica nanoparticles in nanomedicine applications","volume":"29","author":"Manzano","year":"2018","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010047","article-title":"Mesoporous silica nanoparticles for drug delivery: current insights","volume":"23","author":"Vallet-Reg\u00ed","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/cm0011559","article-title":"A new property of MCM-41: drug delivery system","volume":"13","author":"Vallet-Regi","year":"2001","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","article-title":"Mesoporous silica nanoparticles in drug delivery and biomedical applications","volume":"11","author":"Wang","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0225","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/molecules22050782","article-title":"Mesoporous silica nanoparticles as carriers for intracellular delivery of nucleic acids and subsequent therapeutic applications","volume":"22","author":"Cha","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0230","article-title":"Injectable hydrogel with MSNs\/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4236\/wjns.2018.81006","article-title":"Activated microglia in the brain: mitochondrial and cell membrane-associated targets for positron emission tomography","volume":"8","author":"Pissarek","year":"2019","journal-title":"World J. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2018.04.011","article-title":"Mesoporous silicate nanoparticles\/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering","volume":"279","author":"Yao","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0245","article-title":"Mesoporous porphyrinic metal-organic framework nanoparticles\/3D nanofibrous scaffold as a versatile platform for bone tumor therapy","volume":"24","author":"Pan","year":"2022","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0250","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acs.nanolett.8b04020","article-title":"Polysialic-acid-based micelles promote neural regeneration in spinal cord injury therapy","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0255","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100414RR","article-title":"Adenosine A(2A) receptor antagonism protects against hyperoxia-induced retinal vascular loss via cellular proliferation","volume":"35","author":"Zhong","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0260","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0265","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1096\/fj.201601285R","article-title":"Caffeine preferentially protects against oxygen-induced retinopathy","volume":"31","author":"Zhang","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0270","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0275","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1039\/C5NR06122A","article-title":"Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery","volume":"8","author":"Heidegger","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0280","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0290","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2217\/nnm.15.39","article-title":"Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers","volume":"10","author":"Parodi","year":"2015","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/IJN.S150918","article-title":"Lipopolysaccharide-induced inflammation in monocytes\/macrophages is blocked by liposomal delivery of G(i)-protein inhibitor","volume":"13","author":"Tucureanu","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0300","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2009-01-197095","article-title":"AlphaB-crystallin regulation of angiogenesis by modulation of VEGF","volume":"115","author":"Kase","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0305","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0310","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.15252\/emmm.201404922","article-title":"Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis","volume":"7","author":"Yang","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0315","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1167\/iovs.13-11625","article-title":"Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity","volume":"54","author":"McCloskey","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.006_bb0320","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0325","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","article-title":"Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity","volume":"37","author":"Wu","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0330","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/IAE.0000000000000535","article-title":"Plasma concentrations of vascular endothelial growth factor in retinopathy of prematurity after intravitreal bevacizumab injection","volume":"35","author":"Hong","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2022.08.006_bb0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2009.10.003","article-title":"MicroRNA: emerging therapeutic targets in acute ischemic diseases","volume":"125","author":"Fasanaro","year":"2010","journal-title":"Pharmacol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:36:43Z","timestamp":1759163803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922004862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":67,"alternative-id":["S0168365922004862"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}